http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021337807-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62be1bb5b9ad4185e041f0ce0dfc0c12 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-84 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N65-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N65-00 |
| filingDate | 2019-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7877ead2c9a60f7bbdfdd1de6af5ffda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d09d7470a7471e2b0e6be9e6cbfe55d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb2d1045bd8b27a7eb4acad562414b8a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_935779f26964ab630caca9da64206fe8 |
| publicationDate | 2021-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021337807-A1 |
| titleOfInvention | Biologically active substance, method for manufacturing same and use thereof as an agent for protecting a biological tissue |
| abstract | The biologically active substance is obtained or capable of being obtained by alkaline extraction, using an aqueous solution of at least one base in the presence of at least one reducing agent, of at least one macroscopic edible mushroom reduced to powder, to obtain a mixture having a liquid portion containing the soluble extracted materials and a solid portion formed of insoluble solid particles; filtering the resulting mixture to remove the solid portion and optionally clarifying the liquid portion; neutralising the liquid portion using a cation exchange resin and optionally filtering/clarifying the liquid portion thus neutralised to obtain the biologically active substance in the aqueous phase; and treating the resulting aqueous phase, the treatment being selected from dilution in water, concentration, dehydration and lyophilisation to obtain a biologically active substance which is, respectively, more diluted in water, in an aqueous solution more concentrated, dehydrated in powder form or lyophilised. |
| priorityDate | 2018-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 225.